MEDPAL AI is trading 6.4% up at £3.99, with the catalyst currently unclear.
- No company-specific announcement dated August 26, 2026 was identified; the latest RNS was August 11, concerning Eli Lilly’s once-daily GLP-1 pill.
- The broader market was mixed and subdued, so it does not clearly explain the move.
- Further monitoring is warranted for delayed disclosure.